...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: OUCH!!! Things Move Faster In The Cancer Arena and Other Gems

...if you are a long time holder than these Zenith shares were given for free....

SF is correct on that.  Right after the split, RVX dropped by the perceived value of the Zenith shares.  The Zenith shares were not "free".

Share
New Message
Please login to post a reply